In Vitro DMPK

Curia’s drug metabolism and pharmacokinetics (DMPK) group delivers expert solutions for your drug discovery programs. Providing in vitro DMPK services that span all stages of drug discovery, from exploratory, hit-to-lead, lead optimization, to candidate selection.

Our team combines expertise in biochemistry, enzymology, pharmacokinetics, analytical chemistry, mass spectrometry, cell biology, pharmacology and toxicology to provide DMPK and bioanalytical/pharmacokinetic services that span all stages of drug discovery.

Your compound is in the safe hands of an experienced team that brings strong problem-solving skills and expertise in a large variety of assays and techniques used to assess drug absorption, distribution, metabolism and excretion (ADME) in vitro.

Our complete suite of services includes:

• Comprehensive set DMPK assays 
• Drug metabolite identification, synthesis and bioanalysis
• Expert pre-clinical IND-enabling program support

Partner with us and we’ll deliver high-quality data that identifies DMPK liabilities and guides the structure property relationships (SPRs) of your project compounds.